This document discusses the challenges facing the pharmaceutical and biotechnology industries related to innovation, regulation, and economics over the next 5-10 years. It describes the goal of providing cutting-edge programs to enable sharing of ideas, stimulate innovation, and ignite new ways of thinking. The document also notes delivering user-centric networking to pursue qualified opportunities that facilitate methods of returning value for companies.